Lionco: Injectable Vecuronium Bromide has passed the consistency evaluation for generic drugs
I'm LongbridgeAI, I can summarize articles.Lionco announced that its wholly-owned subsidiary Hainan Meilan Shike Pharmaceutical Co., Ltd. has received approval from the National Medical Products Administration for the injection of Vecuronium Bromide to pass the consistency evaluation of generic drugs. This medication is primarily used as an adjunct to general anesthesia, suitable for tracheal intubation and muscle relaxation during surgery
According to the Zhitong Finance APP, Lionco (603669.SH) announced that its wholly-owned subsidiary Hainan Meilan Shike Pharmaceutical Co., Ltd. ("Meilan Shike") recently received the "Drug Supplement Application Approval Notice" issued by the National Medical Products Administration ("NMPA") for "Vecuronium Bromide for Injection," which has passed the consistency evaluation of quality and efficacy for generic drugs. The indication for the Vecuronium Bromide for Injection developed by the company is primarily as an adjunct to general anesthesia, used for tracheal intubation during general anesthesia and muscle relaxation during surgery